PERCUTANEOUS
CLOSURE OF SECUNDUM ATRIAL SEPTAL DEFECTS WITH THE AMPLATZER OCCLUDER:
EARLY CLINICAL EXPERIENCE AND ECHOCARDIOGRAPHIC FOLLOW-UP.
P.C.
Hayes,* D.W. Muller, R.P. Kelly, D.W. Baron, P.R. Roy, M.P.
Feneley.
Cardiology
Department, St Vincent's Hospital, Darlinghurst, NSW.
OBJECTIVE:
To evaluate the efficacy and safety of percutaneous closure of
secundum atrial septal defects (ASD) in adults with the Amplatzer
occluder.
METHOD
AND RESULTS: Between October 1998 and November 1999, percutaneous
ASD closure was attempted in 27 patients. All procedures
were performed under transoesophageal echocardiographic (TOE)
and fluoroscopic guidance. he mean ASD diameter was 16.8±6.1(6.5-30)
mm on TOE. The mean occluder size was 23.9±6.3(14-38)
mm. Echocardiographic or catheter-derived pulmonary artery systolic
pressure exceeded 35 mmHg in 8 of 25 pts examined (32%).
Devices were deployed successfully in 25 pts (93%). The
procedure was abandoned in 2 pts after 1 or more unsuccessful
attempts. There were no episodes of device embolism.
Mean procedure time was 80.2±20.2(42-120) mins. Mean
fluoroscopy time was 13.9±10.7(4.8-54.3) mins. Average
post-procedural length of stay was 1.96 (1-5) days. Complications
included: tamponade drained percutaneously in one; reversible
jaw subluxation in one and dental trauma in two. At 10-12
weeks follow up, 3 pts have a residual left-to-right shunt <
1.5:1. Right ventricular (RV) dilatation was present in
all patients at baseline. Echocardiographic follow-up in 16 pts
at 3 months showed a significant reduction in RV size from 36.6±7.7
to 30.6±6.2mm (p<0.002). Intermittent atrial fibrillation
or flutter was present in 6 pts pre-closure, and the frequency
of episodes decreased in 3 and remained unchanged in 3 post-closure.
New atrial fibrillation or flutter was documented in 3 pts following
device placement, and persists in one patient. There were
no documented cases of endocarditis or thromboembolism in 215
patient-months of follow up.
CONCLUSIONS:
Percutaneous ASD closure with the Amplatzer occluder is effective
and can be performed with low morbidity.